Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.22.2.2
Stock-Based Compensation
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

9. Stock-Based Compensation

 

A summary of the Company’s outstanding stock option activity for the three months ended September 30, 2022, and 2021 is as follows:

 

          September 30, 2022        
         

Weighted-

Average

   

Weighted-

Average

Remaining

Contractual
Life

    Intrinsic  
    Options     Exercise Price     (Years)     Value  
As of December 31, 2021     833,892     $ 3.91       8.7       87,553  
Granted     357,000       0.45       10.0       -  
Exercised     -       -       -       -  
Forfeited     -       -       -       -  
Expired     (3 )     139,237.86       -       -  
As of September 30, 2022     1,190,889     $ 2.38       8.4     $ -  
Exercisable at September 30, 2022     537,246     $ 4.64       7.8     $ -  
Vested and expected to vest at September 30, 2022     1,105,071     $ 2.48       8.4     $ -  

 

          September 30, 2021        
         

Weighted-

Average

   

Weighted-

Average

Remaining

Contractual Life

    Intrinsic  
    Options     Exercise Price     (Years)     Value  
As of December 31, 2020     465,393     $ 5.53       9.3       -  
Granted     368,500       1.93       10.0       -  
Exercised     -       -       -       -  
Forfeited     -       -       -       -  
Expired     -       -       -       -  
As of September 30, 2021     833,893     $ 3.98       8.9     $ 417,164  
Exercisable at September 30, 2021     221,834     $ 12.26       8.6     $ -  
Vested and expected to vest at September 30, 2021     833,893     $ 3.98       8.9     $ 417,164  

 

The Company estimates the fair value of each stock option on the grant date using the Black-Scholes-Merton valuation model, which requires several estimates including an estimate of the fair value of the underlying common stock on grant date. The expected volatility was based on an average of the historical volatility of the Company. The expected term was contractual life of option. The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option. The following weighted average assumptions were used in the calculation to estimate the fair value of options granted to employees and non-employees during the nine months ended September 30, 2022. During the nine months ended September 30, 2022, the Company granted stock options with an estimated fair value of approximately $0.2 million.

 

    September 30, 2022  
Weighted-average risk-free interest rate     1.70 %
Weighted-average expected life (in years)     5.5  
Expected dividend yield     - %
Weighted-average expected volatility     131.1 %

 

Of the 357,000 options granted during the nine months ended September 30, 2022, 60,000 were to non-executive members of the board of directors. Of the 1,190,889 options outstanding as of September 30, 2022, 355,000 were awarded to non-executive members of the board of directors.

 

Unrecognized stock-based compensation as of September 30, 2022, is as follows (in thousands):

 

         

Weighted

Average

 
   

Unrecognized

Stock-Based

   

Remaining of

Recognition

 
    Compensation     (in years)  
Stock options   $ 431       1.5  
Stock grants   $ 32       1.7